| Description |
Publish Date |
LINKS |
| Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck |
15/02/2024 |
 |
| Important safety information on Varilrix in Mauritius (November 2020) |
4/11/2020 |
 |
| Important safety information on Varilrix in Mauritius (January 2021) |
21/01/2021 |
|
| Important safety information on Resorcinol in Mauritius |
23/02/2022 |
|
| Important safety information on Cephalosporins in Mauritius (Safety Notification_Cephalosporins and risk of seizure) |
01/03/2023 |
|
Important safety information on Cephalosporins in Mauritius (Safety Notification_Cephalosporins and risk of neurotoxicity) |
07/03/2023 |
|
Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Mauritius |
09/09/2023 |
|
| Important safety information on Paroxetine in Mauritius (Safety Notification_EMA communication issued relating to Paroxetine label update) |
27-10-2023 |
|
| Important safety information on Topical Corticosteroids containing products in Mauritius |
15-11-2023 |
|
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates |
19/12/2023 |
|
Important safety information on Zanamivir containing products - Precautions for prescribing and administering flu medications (zanamivir) |
26/12/2023 |
|
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine |
27/12/2023 |
|
